These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19231693)
1. [Lichenoid eruption in a patient with chronic hepatitis C virus infection treated with interferon and ribavirin]. Guillermo N; Hernández Santana J; Borrego L; Jorge M Gastroenterol Hepatol; 2009 Feb; 32(2):130-1. PubMed ID: 19231693 [No Abstract] [Full Text] [Related]
2. Lichen Aureus associated with interferon-alfa plus ribavirin. Baraldi C; Dika E; Barisani A; Fanti PA; Patrizi A; Vaccari S G Ital Dermatol Venereol; 2017 Feb; 152(1):86-88. PubMed ID: 27978614 [No Abstract] [Full Text] [Related]
3. Cutaneous reactions to interferon and ribavirin. Chamberlain AJ; Poon E Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557 [No Abstract] [Full Text] [Related]
4. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891 [No Abstract] [Full Text] [Related]
5. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Moore MM; Elpern DJ; Carter DJ Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798 [TBL] [Abstract][Full Text] [Related]
6. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. Hashimoto Y; Kanto H; Itoh M J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392 [TBL] [Abstract][Full Text] [Related]
7. [Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon]. Rosel L; Blanco JR; Metota L; Oteo JA Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):497-8. PubMed ID: 15482692 [No Abstract] [Full Text] [Related]
8. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Sookoian S; Neglia V; Castaño G; Frider B; Kien MC; Chohuela E Arch Dermatol; 1999 Aug; 135(8):1000-1. PubMed ID: 10456365 [No Abstract] [Full Text] [Related]
10. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835 [TBL] [Abstract][Full Text] [Related]
11. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment. Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535 [No Abstract] [Full Text] [Related]
12. Lichen aureus induced by interferon-alpha plus ribavirin. González-Sixto B; García-Doval I; Conde A; Mayo E; Pardavila R; De La Torre C; Cruces M Acta Derm Venereol; 2007; 87(1):87-8. PubMed ID: 17225027 [No Abstract] [Full Text] [Related]
13. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection. Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630 [No Abstract] [Full Text] [Related]
14. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C. Tavakoli-Tabasi S; Bagree A J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144 [TBL] [Abstract][Full Text] [Related]
15. How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients. Kasahara A J Gastroenterol; 2004 Nov; 39(11):1125-6. PubMed ID: 15580413 [No Abstract] [Full Text] [Related]
16. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection. Sidhu-Malik NK; Kaplan AL J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408 [TBL] [Abstract][Full Text] [Related]
17. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C. Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485 [No Abstract] [Full Text] [Related]
18. Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency. Demelia L; Civolani A; Murgia D; Murru A; Sorbello O; Rizzetto M J Hepatol; 2007 Jan; 46(1):171-3. PubMed ID: 17107736 [No Abstract] [Full Text] [Related]
19. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection. Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829 [No Abstract] [Full Text] [Related]
20. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Kartal ED; Alpat SN; Ozgunes I; Usluer G Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):817-20. PubMed ID: 17700271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]